Oct 27, 2016 11:05 am UTC| Business
LEIDEN, the Netherlands, Oct. 27, 2016 -- ProQR Therapeutics N.V. (Nasdaq:PRQR) today announced that clinical study PQ-010-002, a proof-of-concept study of nasal potential difference (NPD), demonstrated that QR-010...
Oct 27, 2016 11:05 am UTC| Business
LEIDEN, the Netherlands, Oct. 27, 2016 -- ProQR Therapeutics N.V. (Nasdaq:PRQR) today announced that clinical study PQ-010-002, a proof-of-concept study of nasal potential difference (NPD), demonstrated that QR-010...
Oct 27, 2016 11:04 am UTC| Business
SOUTH SAN FRANCISCO, Calif., Oct. 27, 2016 -- Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) today announced that it will host a conference call on Thursday, November 3, 2016 at 11:00 a.m. Eastern Time to discuss corporate...
Immunomedics Announces Conference Call and Webcast for First Quarter Fiscal 2017 Results
Oct 27, 2016 11:04 am UTC| Business
MORRIS PLAINS, N.J., Oct. 27, 2016 -- Immunomedics, Inc. (Nasdaq:IMMU) today announced that it will host a conference call and live audio webcast on Wednesday, November 2, 2016 at 5:00 p.m. Eastern Time to discuss...
Oct 27, 2016 11:04 am UTC| Business
DANVERS, Mass., Oct. 27, 2016 -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the U.S. Food and Drug Administration (FDA) approval of a...
Hudson Global Reports 2016 Third Quarter Results
Oct 27, 2016 11:04 am UTC| Business
NEW YORK, Oct. 27, 2016 -- Hudson Global, Inc. (Nasdaq:HSON), a leading global talent solutions company, today announced financial results for the third quarter ended September30, 2016. 2016 Third Quarter Summary ...
Abiomed Announces Q2 FY 2017 Revenue of $103 Million, Up 35% Over Prior Year
Oct 27, 2016 11:04 am UTC| Business
- Impella® Heart Pumps Assigned to Heart Assist System Implant, MS-DRG 215 DANVERS, Mass., Oct. 27, 2016 -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported...